{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:14:56Z","timestamp":1784697296007,"version":"3.55.0"},"reference-count":29,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Relative-tachycardia (RT), a phenomenon of unproportionately high heart-rate elevation in response to fever, has been previously attributed to unfavourable outcomes in severe-inflammatory-response-syndrome (SIRS). Relative heart-rate to body-temperature ratio (RHR) and its prognostic associations in patients with severe and critical coronavirus disease 2019 (COVID-19) have not been investigated. Methods: We retrospectively analyzed heart-rate and body-temperature data at admission in patients who were hospitalized due to COVID-19 at a tertiary center from March 2020 to June 2021. After excluding patients with known heart rate affecting medications (beta-blockers and other antiarrhythmics) and atrial fibrillation, a total of 3490 patients were analyzed. Patients were divided into quartiles based on RHR on admission, with patients belonging to the 1st quartile designated as having relative-bradycardia (RB) and patients belonging to 4th quartile designated as having RT. Comparisons with baseline clinical characteristics and the course of treatment were done. Results: There were 57.5% male patients. Median age was 69 years. Most patients had severe or critical COVID-19 at admission. Median heart-rate at the time of hospital admission was 90\/min, median body-temperature was 38 \u00b0C, and median RHR was 2.36 with interquartile-range 2.07\u20132.65. RB in comparison to middle-range RHR was significantly associated with older age, higher comorbidity burden, less severe COVID-19 and less pronounced inflammatory profile, and in comparison to RT additionally with higher frequency of hyperlipoproteinemia but lower frequency of obesity. RT in comparison to middle-range RHR was significantly associated with younger age, more severe COVID-19, lower comorbidity burden, lower frequency of arterial hypertension, higher frequency of diabetes mellitus, and more pronounced inflammatory profile. In multivariate analyses adjusted for clinically meaningful parameters, RB patients experienced more favorable survival compared to RT, whereas RT patients experienced higher mortality in comparison to RB and middle-range RHR patients, independently of older age, male sex, higher comorbidity burden and higher COVID-19 severity. Conclusions: Heart rate and axillary temperature are an indispensable part of a clinical exam, easy to measure, at effectively no cost. RT at admission, as a sign of excessive activation of the sympathetic nervous system, is independently associated with fatal outcomes in COVID-19 patients.<\/jats:p>","DOI":"10.31083\/j.rcm2408238","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T07:27:25Z","timestamp":1692343645000},"source":"Crossref","is-referenced-by-count":6,"title":["Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients"],"prefix":"10.31083","volume":"24","author":[{"given":"Petra","family":"Bistrovic","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Besic","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Cikara","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Antolkovic","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Bakovic","sequence":"first","affiliation":[{"name":"Colorectal Surgery Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Radic","sequence":"first","affiliation":[{"name":"Cardiology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Stojic","sequence":"first","affiliation":[{"name":"Gastroenterology, Hepatology and Clinical Nutrition Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besa","family":"Osmani","sequence":"first","affiliation":[{"name":"Nephrology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Hrabar","sequence":"first","affiliation":[{"name":"Endocrinology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julija","family":"Martinkovic","sequence":"first","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Delic-Brkljacic","sequence":"first","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Cardiology Department, University Hospital Center Sisters of Mercy, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Lucijanic","sequence":"first","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Hematology Department, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, et al. Cardiac complications in patients hospitalised with COVID-19. European Heart Journal. Acute Cardiovascular Care. 2020; 9: 817\u2013823.","DOI":"10.1177\/2048872620974605"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American Journal of Emergency Medicine. 2020; 38: 1504\u20131507.","DOI":"10.1016\/j.ajem.2020.04.048"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. The Cochrane Database of Systematic Reviews. 2021; 3: CD013879.","DOI":"10.1002\/14651858.CD013879"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Mehta N, Mazer-Amirshahi M, Alkindi N, Pourmand A. Pharmacotherapy in COVID-19; A narrative review for emergency providers. The American Journal of Emergency Medicine. 2020; 38: 1488\u20131493.","DOI":"10.1016\/j.ajem.2020.04.035"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Touafchia A, Bagheri H, Carri\u00e9 D, Durrieu G, Sommet A, Chouchana L, et al. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021. (online ahead of print)","DOI":"10.1016\/j.cmi.2021.02.013"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Bistrovic P, Lucijanic M. Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study. Journal of Medical Virology. 2021; 93: 5724\u20135725.","DOI":"10.1002\/jmv.27177"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mohammad M, Emin M, Bhutta A, Gul EH, Voorhees E, Afzal MR. Cardiac arrhythmias associated with COVID-19 infection: state of the art review. Expert Review of Cardiovascular Therapy. 2021; 19: 881\u2013889.","DOI":"10.1080\/14779072.2021.1997589"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Jammoul M, Naddour J, Madi A, Reslan MA, Hatoum F, Zeineddine J, et al. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Autonomic Neuroscience: Basic & Clinical. 2023; 245: 103071.","DOI":"10.1016\/j.autneu.2022.103071"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ye F, Winchester D, Stalvey C, Jansen M, Lee A, Khuddus M, et al. Proposed mechanisms of relative bradycardia. Medical Hypotheses. 2018; 119: 63\u201367.","DOI":"10.1016\/j.mehy.2018.07.014"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clinical Microbiology and Infection. 2000; 6: 633\u2013634.","DOI":"10.1046\/j.1469-0691.2000.0194f.x"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Capoferri G, Osthoff M, Egli A, Stoeckle M, Bassetti S. Relative bradycardia in patients with COVID-19. Clinical Microbiology and Infection. 2021; 27: 295\u2013296.","DOI":"10.1016\/j.cmi.2020.08.013"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ikeuchi K, Saito M, Yamamoto S, Nagai H, Adachi E. Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerging Infectious Diseases. 2020; 26: 2504\u20132506.","DOI":"10.3201\/eid2610.202648"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Davies P, Maconochie I. The relationship between body temperature, heart rate and respiratory rate in children. Emergency Medicine Journal. 2009; 26: 641\u2013643.","DOI":"10.1136\/emj.2008.061598"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Broman ME, Vincent JL, Ronco C, Hansson F, Bell M. The Relationship Between Heart Rate and Body Temperature in Critically Ill Patients. Critical Care Medicine. 2021; 49: e327\u2013e331.","DOI":"10.1097\/CCM.0000000000004807"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S, et al. Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM. 2007; 100: 629\u2013634.","DOI":"10.1093\/qjmed\/hcm074"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, et al. Effects of \u03b2-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Frontiers in Immunology. 2021; 12: 749291.","DOI":"10.3389\/fimmu.2021.749291"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Seid S, Adane H, Mekete G. Patterns of presentation, prevalence and associated factors of mortality in ICU among adult patients during the pandemic of COVID 19: A retrospective cross-sectional study. Annals of Medicine and Surgery (2012). 2022; 77: 103618.","DOI":"10.1016\/j.amsu.2022.103618"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Bhavani SV, Verhoef PA, Maier CL, Robichaux C, Parker WF, Holder A, et al. Coronavirus Disease 2019 Temperature Trajectories Correlate with Hyperinflammatory and Hypercoagulable Subphenotypes. Critical Care Medicine. 2022; 50: 212\u2013223.","DOI":"10.1097\/CCM.0000000000005397"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"D\u00fcnser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. Journal of Intensive Care Medicine. 2009; 24: 293\u2013316.","DOI":"10.1177\/0885066609340519"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Sander O, Welters ID, Fo\u00ebx P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Critical Care Medicine. 2005; 33: 81\u201388; discussion 241\u2013242.","DOI":"10.1097\/01.CCM.0000150028.64264.14"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Chacko CJ, Gopal S. Systematic review of use of \u03b2-blockers in sepsis. Journal of Anaesthesiology, Clinical Pharmacology. 2015; 31: 460\u2013465.","DOI":"10.4103\/0970-9185.169063"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Collazo E, Avenda\u00f1o-Ortiz J, Mart\u00edn-Quir\u00f3s A, Aguirre LA. Immune Response and COVID-19: A mirror image of Sepsis. International Journal of Biological Sciences. 2020; 16: 2479\u20132489.","DOI":"10.7150\/ijbs.48400"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, et al. Sympathetic activation: a potential link between comorbidities and COVID-19. The FEBS Journal. 2020; 287: 3681\u20133688.","DOI":"10.1111\/febs.15481"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Clemente-Morag\u00f3n A, Mart\u00ednez-Milla J, Oliver E, Santos A, Flandes J, Fern\u00e1ndez I, et al. Metoprolol in Critically Ill Patients with COVID-19. Journal of the American College of Cardiology. 2021; 78: 1001\u20131011.","DOI":"10.1016\/j.jacc.2021.07.003"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Bistrovic P, Manola S, Lucijanic M. Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre. Postgraduate Medical Journal. 2022; 98: 501\u2013502.","DOI":"10.1136\/postgradmedj-2021-141079"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bistrovic P, Manola S, Papic I, Jordan A, Ortner Hadziabdic M, Lucijanic M. Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis. The American Journal of Emergency Medicine. 2022; 59: 182\u2013183.","DOI":"10.1016\/j.ajem.2022.04.051"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Rodr\u00edguez N, Binkyt\u0117 R, Bakkali W, Bookseller S, Tubaro P, Bacevi\u010dius A, et al. Gender and sex bias in COVID-19 epidemiological data through the lens of causality. Information Processing & Management. 2023; 60: 103276.","DOI":"10.1016\/j.ipm.2023.103276"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Cereda A, Toselli M, Palmisano A, Vignale D, Leone R, Nicoletti V, et al. The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification. GeroScience. 2021; 43: 2215\u20132229.","DOI":"10.1007\/s11357-021-00409-y"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Piska\u010d \u017divkovi\u0107 N, Lucijani\u0107 M, Bu\u0161i\u0107 N, Jurin I, Ati\u0107 A, Andrilovi\u0107 A, et al. The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry. Croatian Medical Journal. 2022; 63: 36\u201343.","DOI":"10.3325\/cmj.2022.63.36"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/8\/10.31083\/j.rcm2408238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T19:07:11Z","timestamp":1732734431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/24\/8\/10.31083\/j.rcm2408238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"alternative-id":["S1530-6550(23)01081-5"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2408238","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"article-number":"238"}}